title: Potential control of antipsychotic-induced hyperprolactinemia and obesity in children and adolescents by aripiprazole.
authors.forename: Jiamei
authors.initials: J
authors.lastname: Lian
authors.forename: Xu-Feng
authors.initials: XF
authors.lastname: Huang
authors.forename: Nagesh
authors.initials: N
authors.lastname: Pai
authors.forename: Chao
authors.initials: C
authors.lastname: Deng
mesh_terms: D000293:Adolescent; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000188:drug therapy*; D002648:Child; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced*; D009765:Obesity / Q000139:chemically induced*; D010879:Piperazines / Q000627:therapeutic use*; D015363:Quinolones / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*
chemical_list: D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole